Adnan K Salameh

This inventor holds 10 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Allergan, Inc.. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adnan K Salameh. Retrieved from https://idiyas.com/inventor/adnan-k-salameh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 16)

% Patents Active = 70.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 60(Granted Patents)

Company Filing History:

10 out of 2,287

Allergan, Inc.

patents

Years Active: 2015-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10905696 - Androgen composition for treating an ophthalmic condition (2021-02-02),

2. 10780098 - Non-irritating testosterone emulsions (2020-09-22),

3. 9937188 - Non-irritating testosterone emulsions (2018-04-10),

4. 9849140 - Topical compositions comprising bimatoprost and methods for stimulating hair growth therewith (2017-12-26),

5. 9763959 - Compositions and methods for stimulating hair growth (2017-09-19),

6. 9750750 - Compositions and methods for stimulating hair growth (2017-09-05),

7. 9504646 - Androgen composition for treating an opthalmic condition (2016-11-29),

8. 9149484 - Compositions and methods for stimulating hair growth (2015-10-06),

9. 9138480 - Compositions and methods for stimulating hair growth (2015-09-22),

10. 9119772 - Androgen composition for treating an opthalmic condition (2015-09-01),

Title: Adnan K Salameh: Innovator in Ophthalmic Treatments

Introduction

Adnan K Salameh is a prominent inventor based in Irvine, CA, known for his significant contributions to the field of ophthalmology. With a total of 10 patents to his name, Salameh has focused on developing innovative treatments for ocular conditions. His work has the potential to greatly enhance the quality of life for individuals suffering from various eye disorders.

Latest Patents

Salameh's latest patents include groundbreaking compositions aimed at treating ophthalmic conditions. One notable patent is for an androgen composition designed for treating an ocular condition. This disclosure provides compositions that comprise a physiologically effective amount of an androgen, suitable for topical administration to the eye. Additionally, he has developed non-irritating testosterone emulsions, which include testosterone or related androgens, castor oil, cyclodextrin, Pemulen TR-2, Polyoxyl 40, and other ingredients. These emulsions are particularly useful for treating keratoconjunctivitis sicca and meibomian gland disease.

Career Highlights

Adnan K Salameh has made significant strides in his career, particularly through his work at Allergan, Inc. His innovative approach to ophthalmic treatments has positioned him as a key figure in the industry. His dedication to research and development has led to advancements that benefit patients and healthcare providers alike.

Collaborations

Throughout his career, Salameh has collaborated with notable colleagues, including Chetan Pujara and John T Trogden. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.

Conclusion

Adnan K Salameh's contributions to ophthalmology through his innovative patents and collaborations highlight his commitment to improving patient care. His work continues to pave the way for new treatments that address critical ocular conditions.

Profile summary based on public USPTO records.